Search results
ImmunoGen (IMGN) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Singapore Finance· 7 months agoFrom a technical perspective, ImmunoGen (IMGN) is looking like an interesting pick, as it just...
Should You Buy ImmunoGen (IMGN) After Golden Cross?
Zacks via Yahoo Singapore Finance· 1 year agoAfter reaching an important support level, ImmunoGen, Inc. (IMGN) could be a good stock pick from a technical perspective. IMGN recently experienced a...
Wall Street Analysts Think ImmunoGen (IMGN) Could Surge 49.11%: Read This Before Placing a Bet
Zacks via Yahoo Singapore Finance· 9 months agoThe mean of analysts' price targets for ImmunoGen (IMGN) points to a 49.1% upside in the stock....
Zacks.com featured highlights include Confluent, Pinterest, ICON and ImmunoGen
Zacks via Yahoo Singapore Finance· 8 months agoFor Immediate Release Chicago, IL – November 8, 2023 – Stocks in this week’s article are Confluent...
ImmunoGen (IMGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Singapore Finance· 7 months agoWhile the top- and bottom-line numbers for ImmunoGen (IMGN) give a sense of how the business...
AbbVie signs $10 billion deal to buy cancer drugmaker ImmunoGen
Reuters via Yahoo Singapore Finance· 7 months agoThe deal, which prices ImmunoGen's stock at a 95% premium, could boost AbbVie's plans to expand into...
ImmunoGen (IMGN) Q3 Earnings and Revenues Top Estimates
Zacks via Yahoo Singapore Finance· 8 months agoImmunoGen (IMGN) delivered earnings and revenue surprises of 400% and 6.02%, respectively, for the...
Here's Why You Should Add ImmunoGen (IMGN) to Your Portfolio Now
Zacks via Yahoo Singapore Finance· 1 year agoImmunoGen's (IMGN) recently launched drug, Elahere, is expected to generate incremental revenues for...
ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why
Zacks via Yahoo Singapore Finance· 1 year agoImmunoGen (IMGN) shares surge exponentially in the past month owing to the positive data on the...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Singapore Finance· 2 months agoAbbVie's acquisition of ImmunoGen strengthens its oncology pipeline and solid tumor capabilities. Robust financial performance with $12.3 billion in net...
